Page last updated: 2024-10-29

ketoconazole and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ketoconazole has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 5 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
" Additionally, voriconazole could significantly increase Cmax of dasatinib by approximately 4."1.56Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS. ( Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y, 2020)
"Bosutinib is an orally available Src/Abl tyrosine kinase inhibitor indicated for the treatment of patients with Philadelphia chromosome-positive chronic myelogenous leukemia."1.46Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions. ( Abbas, R; Hsyu, PH; Loi, CM; Ono, C; Yamazaki, S, 2017)
"The hallmark of chronic myeloid leukemia (CML) is the presence of the bcr-abl oncogene, which is associated with transforming ability and an intrinsic resistance to induction of apoptosis by genotoxic agents."1.30Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. ( Akard, L; Boswell, HS; Carlo-Stella, C; Dugan, M; Garau, D; Regazzi, E; Rizzo, MT; Rizzoli, V, 1999)
"The rhabdomyolysis was preceded by a grand mal seizure probably caused by a combination of cyclosporin A and corticosteroids given for the prevention and treatment of acute graft-versus-host disease."1.28Fatal rhabdomyolysis as a complication of bone marrow transplantation. ( Järventie, G; Ruutu, T; Volin, L, 1990)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Prado-Carrillo, O1
Arenas-Ramírez, A1
Llaguno-Munive, M1
Jurado, R1
Pérez-Rojas, J1
Cervera-Ceballos, E1
Garcia-Lopez, P1
Luo, X1
Xue, X1
Li, T1
Zhang, Y1
Huang, L1
Cheng, G1
Ono, C1
Hsyu, PH1
Abbas, R1
Loi, CM1
Yamazaki, S1
Rizzo, MT1
Regazzi, E1
Garau, D1
Akard, L1
Dugan, M1
Boswell, HS1
Rizzoli, V1
Carlo-Stella, C1
Volin, L1
Järventie, G1
Ruutu, T1

Other Studies

5 other studies available for ketoconazole and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells.
    International journal of molecular sciences, 2022, Jul-13, Volume: 23, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Doxorubicin; Drug R

2022
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
    Current drug metabolism, 2020, Volume: 21, Issue:13

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Li

2020
Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
    Drug metabolism and disposition: the biological fate of chemicals, 2017, Volume: 45, Issue:4

    Topics: Administration, Oral; Aniline Compounds; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP

2017
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
    Cancer research, 1999, Oct-01, Volume: 59, Issue:19

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Bone Mar

1999
Fatal rhabdomyolysis as a complication of bone marrow transplantation.
    Bone marrow transplantation, 1990, Volume: 6, Issue:1

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporins; Graft vs H

1990